Thermalin Diabetes
PrivateLast Round
Series C
Sep 28, 2017
Total Funding Raised
$35.75M
Company Overview
Thermalin Diabetes is a biotechnology company that develops a portfolio of insulin analogs to address the fast-acting and long-acting insulin markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thermalin Diabetes Comparables
Compare Thermalin Diabetes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sensulin | 85% | |
| Metabulin | 85% | |
| Arecor Therapeutics PLC | 77% | |
Thermalin Diabetes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 28, 2017 | ||||
| Grant | Jul 30, 2014 | ||||
| Series B | Jul 30, 2014 | ||||
| Grant | Apr 25, 2012 | ||||
| Series A | Apr 7, 2011 |
Thermalin Diabetes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JumpStart Ventures | Series A |
| JumpStart | Series A |
| NIH RADx | Grant |
| Green Park & Golf Ventures | Series C |
Thermalin Diabetes Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Thermalin Diabetes's valuation, stock price, and market status.